Medistem (MEDS) receives Patent Allowance
12:39 EDT 29 Jun 2012 | Scimitar Equity Blog
Covering the use of fat stem cells, and cells associated with fat stem cells for treatment of diseases related to a dysfunctional immune system MEDS received notice of allowance from the USPTO for a patent covering the use of fat stem cells, a..
Original Article: Medistem (MEDS) receives Patent Allowance
More From BioPortfolio on "Medistem (MEDS) receives Patent Allowance"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
